1. Home
  2. IMRN vs VINE Comparison

IMRN vs VINE Comparison

Compare IMRN & VINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • VINE
  • Stock Information
  • Founded
  • IMRN 1994
  • VINE 2019
  • Country
  • IMRN Australia
  • VINE United States
  • Employees
  • IMRN N/A
  • VINE N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • VINE Beverages (Production/Distribution)
  • Sector
  • IMRN Health Care
  • VINE Consumer Staples
  • Exchange
  • IMRN Nasdaq
  • VINE Nasdaq
  • Market Cap
  • IMRN 15.0M
  • VINE 12.3M
  • IPO Year
  • IMRN N/A
  • VINE 2021
  • Fundamental
  • Price
  • IMRN $2.32
  • VINE $0.83
  • Analyst Decision
  • IMRN Strong Buy
  • VINE
  • Analyst Count
  • IMRN 1
  • VINE 0
  • Target Price
  • IMRN $5.00
  • VINE N/A
  • AVG Volume (30 Days)
  • IMRN 6.0K
  • VINE 329.4K
  • Earning Date
  • IMRN 10-15-2024
  • VINE 11-12-2024
  • Dividend Yield
  • IMRN N/A
  • VINE N/A
  • EPS Growth
  • IMRN N/A
  • VINE N/A
  • EPS
  • IMRN N/A
  • VINE N/A
  • Revenue
  • IMRN $3,271,194.00
  • VINE $1,262,487.00
  • Revenue This Year
  • IMRN N/A
  • VINE N/A
  • Revenue Next Year
  • IMRN N/A
  • VINE N/A
  • P/E Ratio
  • IMRN N/A
  • VINE N/A
  • Revenue Growth
  • IMRN 171.67
  • VINE N/A
  • 52 Week Low
  • IMRN $1.48
  • VINE $0.25
  • 52 Week High
  • IMRN $5.96
  • VINE $1.06
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 33.24
  • VINE 66.68
  • Support Level
  • IMRN $2.66
  • VINE $0.78
  • Resistance Level
  • IMRN $2.87
  • VINE $0.94
  • Average True Range (ATR)
  • IMRN 0.13
  • VINE 0.10
  • MACD
  • IMRN -0.03
  • VINE 0.02
  • Stochastic Oscillator
  • IMRN 16.74
  • VINE 74.55

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About VINE Fresh Vine Wine Inc.

Fresh Vine Wine Inc is a producer of low-carb, low-calorie premium wines in the United States. The company's wine collection features a California Cabernet Sauvignon, Pinot Noir, Chardonnay, California Rose wine, and a Limited Reserve Napa Cabernet.

Share on Social Networks: